Provided by Tiger Trade Technology Pte. Ltd.

Iovance Biotherapeutics, Inc.

9.36
+0.10001.08%
Pre-market: 9.450.0900+0.96%08:15 EDT
Volume:11.09M
Turnover:102.13M
Market Cap:4.24B
PE:-13.26
High:9.38
Open:9.21
Low:8.98
Close:9.26
52wk High:9.41
52wk Low:1.76
Shares:452.97M
Float Shares:394.00M
Volume Ratio:0.85
T/O Rate:2.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7058
EPS(LYR):-1.0941
ROE:-40.36%
ROA:-20.31%
PB:5.76
PE(LYR):-8.55

Loading ...

BRIEF-Iovance's Amtagvi Granted Approval For Treatment Of Advanced Melanoma In Australia

Reuters
·
Jun 04

Iovance receives Australian approval of Amtagvi for advanced melanoma

TIPRANKS
·
Jun 04

Australia TGA approves Iovance Amtagvi for previously treated advanced melanoma

Reuters
·
Jun 04

Iovance’s Amtagvi® (Lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia

THOMSON REUTERS
·
Jun 04

Iovance’s Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia

GlobeNewswire
·
Jun 04

Iovance gets allowance to proceed from FDA for IOV-5001 IND application

TIPRANKS
·
Jun 01

Iovance Biotherapeutics Receives US FDA Clearance to Begin IOV-5001 Trial in Solid Tumors

MT Newswires Live
·
Jun 01

Iovance says FDA clears IND for IL-12 tethered TIL therapy IOV-5001

Reuters
·
Jun 01

Iovance Biotherapeutics Announces Clearance of Investigational New Drug (Ind) Application for Il-12 Tethered Til Therapy Iov-5001

THOMSON REUTERS
·
Jun 01

A Look At Iovance Biotherapeutics (IOVA) Valuation After Recent Share Price Recovery

Simply Wall St.
·
May 31

Iovance grants inducement stock options for 93,340 shares at $3.7 each

Reuters
·
May 23

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
May 23

Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Black Diamond Therapeutics (BDTX) and Iovance Biotherapeutics (IOVA)

TIPRANKS
·
May 22

Can Iovance (IOVA) Turn Early Amtagvi Data and Manufacturing Tweaks into a Durable Advantage?

Simply Wall St.
·
May 22

Iovance Biotherapeutics to Present at Upcoming Conference

GlobeNewswire
·
May 21

What Iovance Biotherapeutics (IOVA)'s Amtagvi Momentum and Narrowing Losses Means For Shareholders

Simply Wall St.
·
May 15

Iovance Biotherapeutics Is Maintained at Buy by Chardan Capital

Dow Jones
·
May 08

Iovance Biotherapeutics price target lowered to $14 from $16 at Chardan

TIPRANKS
·
May 08

BUZZ-U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise

Reuters
·
May 08

Sector Update: Health Care

MT Newswires Live
·
May 08